Bristol-Myers Squibb Co logo

Bristol-Myers Squibb Co - Cedear

NEW
BUE:BMY (USA)   Cedear
ARS 31,600 -340 (-1.06%) Jul 20
16.90
P/B:
6.12
Market Cap:
ARS 181.58T ($ 122.88B)
Enterprise V:
ARS 234.76T ($ 158.86B)
Volume:
498.00
Avg Vol (2M):
1.15K
Trade In:
Volume:
498.00
Avg Vol (2M):
1.15K

Bristol-Myers Squibb Co’s share price is ARS31600. Its GF Value is ARS28100.22. Based on the relationship between the current stock price and the GF Value, GuruFocus believes Bristol-Myers Squibb Co stock is .

The GF Value represents the current intrinsic value of a stock derived from our proprietary algorithm. It is based primarily on the historical multiples of where the stocks have been traded and the future growth of the business, adjusted for the past returns and growth. The GF Value has been verified by backtesting and daily updated model portfolios.

GF Value Growth:

In addition to considering the current valuation, the growth potential of a company's value is equally important. Companies with faster growth rates tend to increase their value more quickly. Therefore, it's essential to look at the Price-to-Future GF Value ratios as well. The results are shown below:

Price: ARS31600 GF Value Price/GF Value
Current ARS28100.22 1.12
Next FY1 End ARS29349.77 1.08
Next 12 Month ARS28965.48 1.09
Next FY2 End ARS28688.14 1.10
Correlation Analysis
Summary:

GuruFocus performed a correlation analysis comparing Bristol-Myers Squibb Co's stock price with key financial metrics: revenue per share, book value per share, EPS without NRI, and operating cash flow per share.

The analysis reveals the strongest correlation between Bristol-Myers Squibb Co's stock price and Book Value per share, with a coefficient of 95%. This is followed by a 92% correlation with Revenue per share and a 89% correlation with Earnings without NRI per share. The weakest correlation is observed with Earnings without NRI per share, at 66%.

Historical Trends of Key Valuation Ratios
GF Value of Related Companies